Enzyme Linked Immunosorbent Assay (ELISA) Market - Global Industry Insights, and Forecast, 2022 - 2028

Enzyme Linked Immunosorbent Assay (ELISA) Market - Global Industry Insights, and Forecast, 2022 - 2028

Enzyme Linked Immunosorbent Assay (ELISA) is one of the promising techniques used for the detection and quantification of biological analytes such as peptides, proteins, antibodies, and hormones. This technique can be useful to provide a quick and cost-effective assay to measure the concentration of unknown antigen or antibody in a specific analyte. ELISA finds its extensive application as a diagnostic tool in medicines as well as to monitor and quality check-up procedures in drug development processes at various industries. ELISA can be performed by different type of methods that include direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA. The high sensitivity, flexibility and cost effectiveness of indirect ELISA makes it an ideal choice of most of the test kit manufacturers and thus possess the highest market share.
Market Dynamics
The Enzyme Linked Immunosorbent Assay (ELISA) Market is expanding owing to the increasing incidence of chronic diseases mainly in case of infectious diseases, vector borne diseases and cancer. According to the National Cancer Institute, cancer has a major impact on the population of U.S. and across the world. The NCI reports approximately 1,685,210 new cases of cancer were diagnosed in 2016. Also, reports demand for efficient detection tests that can be sufficed with the help of ELISA test kits. Moreover, increasing demand for cost-effective diagnostic tool is one of the factor aiding the growth of ELISA market, especially in the low and middle income economies. For instance, in October 2021, the Nigerian government and World Health Organization (WHO) launched a campaign to vaccinate around 874,000 people against yellow fever in two states of the country Kwara and Kogi in alliance with the International Coordination Group. The samples of the patients suspected with yellow fever were further tested with the help of ELISA test at the Pasteur Institute in Dakar. However, availability of alternate immunoassays and cross reactivity projected by these tests can hinder the market growth. Development of cost-effective ELISA tests with improved reliability and accuracy can provide potential opportunity for market players to strategize their growth in the global ELISA market.
Key features of the study:

This report provides in-depth analysis of Enzyme Linked Immunosorbent Assay (ELISA) Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study includes Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Enzyme Linked Immunosorbent Assay (ELISA) Market

Detailed Segmentation:

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:

Chemiluminescent
Colorimetric
Fluorescent

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Geography:

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

U.S.
Canada

North America
Latin America

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

 Europe

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

GCC
Israel
Rest of Middle East

Africa

By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation

By Technology:

Chemiluminescent
Colorimetric
Fluorescent

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Bio-Rad Laboratories, Inc. *

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies

Thermo Fisher Ssienctific, Inc.
ALPCO
BioLegand, Inc.
Biomerieux S.A.
Enzo Life Sciences, Inc.
Zeus Scientific, Inc.
Shenzen YHLO Biotech Co. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.